期刊文献+

慢性乙型肝炎患者肿瘤标志物检测意义探讨

原文传递
导出
摘要 目的:探究慢性乙型肝炎患者肿瘤标志物检测意义.方法:研究进行的时间段在2017年1月~2020年1月,纳入80例慢性乙型肝炎患者和40例健康体检者.对所有观察对象进行分组处理,其中,乙型肝炎分为五个小组,A组(轻度慢性肝炎)20例、B组(中度乙型肝炎)20例、C组(重度乙型肝炎)20例、D组(肝硬变)10例、E组(肝癌)10例,40例健康者为对照组.分别检测各组观察对象的肿瘤标志物,对比分析两组间的差异.结果:不同类型乙型肝炎患者的肿瘤标志物检测结果有所不同,均与普通健康体检者有显著性差异(P<0.05).结论:慢性乙型肝炎患者的肿瘤标志物具有一定的特异性,可以作为临床进行诊断、分类、预后观察的重要项目,准确了解患者病情.
作者 霍喜华
出处 《黑龙江中医药》 2020年第2期117-118,共2页 Heilongjiang Journal of Traditional Chinese Medicine
  • 相关文献

参考文献7

二级参考文献56

  • 1Min Yao,Deng-FuYao,Yin-Zhu Bian,Chong-Guo Zhang,Li-Wei Qiu,Wei Wu,Wen-Li Sai,Jun-Ling Yang,Hai-Jian Zhang.Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量:53
  • 2冷爱民,张桂英.CA125在肝硬化患者中的前瞻性观察[J].世界华人消化杂志,2004,12(7):1759-1760. 被引量:14
  • 3李春艳,刘丽娜,孟华,从令波,宋波.良性腹水患者血清CA125检测的临床意义探讨[J].临床肝胆病杂志,2005,21(4):231-232. 被引量:19
  • 4Yamamoto K, Imamura H, Matsuyama Y, et al. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy [ J ]. Ann Surg Onco1,2009,16 (10) :2795 - 2804.
  • 5Nakamura S,Nouso K,Sakaguchi K,et al. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size [ J ]. Am J Gastroenterol,2006,101 (9) :2038 - 2043.
  • 6Leerapun A, Suravarapu SV, Bida JP, et al. The utility of AFP- L3% in the diagnosis of hepatocellular carcinoma:evaluation in A U. S. referral population [ J ]. Clin Gastroenterol Hepatol, 2007,5( 3 ) :394 - 402.
  • 7Yamamoto K, Imamura H, Matsuyama Y, et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC [ J ]. J Gastroenterol, 2010,45 ( 12 ) : 1272 - 1282.
  • 8Durazo FA, Blatt LM, Corey WG, et al. Des-gamma- carboxyprothrombin, alpha-fetoprotein and AFP-I_3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma [ J ]. Gastroenterol Hepatol,2008,23 (10) : 1541 - 1548.
  • 9Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma [ J ]. Hepatology International, 2010, 4(2) :439 -474.
  • 10Tfinchet JC, Chaffaut C, Bourcier V, et al. Ultraonographic surveillance of hepatocellular carcinoma in cirrhosis : a randomized trial comparing 3-and 6-month periodicities [ J ]. Hepatology,2011,54 (6) : 1987 - 1997.

共引文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部